|
Real-time
Euronext Bruxelles
07:13:26 2026-08-26 am EDT
|
5-day change | 1st Jan Change | ||
| 221.40 EUR | -1.20% |
|
+1.65% | -7.21% |
| Aug. 20 | Cancer vaccines finally garner the spotlight |  |
| Aug. 19 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
| Market Cap | 42.73B 49.86B 40.04B 36.57B 69.02B 4,754B 69.7B 472B 184B 2,398B 187B 183B 7,942B | P/E 2026 * |
22.4x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 43.04B 50.22B 40.33B 36.84B 69.52B 4,788B 70.2B 476B 185B 2,416B 189B 184B 8,000B | EV / Sales 2026 * |
4.95x | EV / Sales 2027 * | 4.23x |
| Free-Float |
61.59% | Yield 2026 * |
0.65% | Yield 2027 * | 0.67% |
Last Transcript: UCB
| 1 day | -1.29% | ||
| 1 week | +1.56% | ||
| Current month | -0.76% | ||
| 1 month | -10.01% | ||
| 3 months | -9.46% | ||
| 6 months | -10.95% | ||
| Current year | -7.29% |
| 1 week | 213.9 |  | 225.4 |
| 1 month | 211.6 | | 251.5 |
| Current year | 211.6 | | 289.5 |
| 1 year | 191.2 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 60 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Buy | Director | 500 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.29% | +1.56% | +10.74% | +169.17% | 49.86B | |
| +0.61% | +2.88% | +45.63% | +0.39% | 83.24B | |
| -0.69% | +3.58% | -19.85% | -35.64% | 59.49B | |
| +14.36% | +152.27% | +526.55% | +41.90% | 63.41B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 52.94B | |
| +1.21% | +3.87% | +61.90% | -16.51% | 32.62B | |
| +1.36% | +5.06% | +53.04% | +103.13% | 26.29B | |
| +9.69% | +11.76% | +14.67% | +215.97% | 22.23B | |
| -0.43% | +0.52% | +61.60% | +123.50% | 17.22B | |
| -4.68% | +2.52% | -9.33% | +752.25% | 15.36B | |
| Average | +0.64% | +18.52% | +74.50% | +139.03% | 42.27B | |
| Weighted average by Cap. | +0.44% | +26.39% | +97.48% | +74.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.69B 10.14B 8.14B 7.44B 14.04B 967B 14.18B 96.05B 37.39B 488B 38.08B 37.25B 1,615B | 9.68B 11.3B 9.07B 8.29B 15.64B 1,077B 15.8B 107B 41.67B 544B 42.43B 41.51B 1,800B |
| Net income | 1.93B 2.25B 1.8B 1.65B 3.11B 214B 3.14B 21.28B 8.28B 108B 8.44B 8.25B 358B | 2.33B 2.72B 2.18B 1.99B 3.76B 259B 3.8B 25.72B 10.01B 131B 10.2B 9.98B 433B |
| Net Debt | 310M 362M 290M 265M 501M 34.48B 506M 3.43B 1.33B 17.4B 1.36B 1.33B 57.61B | -1.81B -2.11B -1.69B -1.55B -2.92B -201B -2.95B -19.96B -7.77B -101B -7.91B -7.74B -336B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | €221.40 | -1.20% | 12,903 |
| 26-08-25 | €224.10 | +1.86% | 150,034 |
| 26-08-24 | €220.00 | -0.77% | 132,150 |
| 26-08-21 | €221.70 | +1.74% | 253,935 |
| 26-08-20 | €217.90 | +0.05% | 183,496 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions
